Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 30 | Okeke Angelique MEVP, General Counsel |  FFIVF5, INC.Open-market sale · 10b5-1 plan | SELL | $326K 1,007 sh | Nov 5, 2026 |
| 62 | Marino Glenn PDirector |  UPBDUPBOUND GROUP, INC.Open-market purchase | BUY | $393K 17.4K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 59 | Langenstein MollyDirector | UPBDUPBOUND GROUP, INC. Open-market purchase | BUY | $50K 2,186 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 55 | Wooters RebeccaEVP, Chief Growth Officer | UPBDUPBOUND GROUP, INC. Open-market purchase | BUY | $99K 4,325 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 54 | Khouri HalimEVP, Chief Financial Officer | UPBDUPBOUND GROUP, INC. Open-market purchase | BUY | $251K 11.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 54 | Brown Jeffrey JDirector | UPBDUPBOUND GROUP, INC. Open-market purchase | BUY | $400K 17.6K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 53 | Sing George LDirector |  REGNREGENERON PHARMACEUTICALS, INC.Open-market sale | SELL | $6.83M 7,073 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 51 | Partners Group Finance (USD) AGAffiliate of the Adviser |  NAPartners Group Growth, LLCOpen-market purchase | BUY | $19.98M 9.51M sh | Nov 4, 2026 traded Nov 1, 2026 |
| 51 | Kumar BalajiEVP, Chief Technology Officer | UPBDUPBOUND GROUP, INC. Open-market purchase | BUY | $50K 2,200 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 49 | Sing George LDirector | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $2.58M 2,670 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 49 | Larosa Joseph JEVP General Counsel and Secret | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $3.80M 3,939 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 49 | Sing George LDirector | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $4.18M 4,338 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 49 | Way T LawrenceDirector |  CUBICustomers Bancorp, Inc.Open-market sale | SELL | $4.09M 48.8K sh | Nov 4, 2026 traded Oct 30, 2026 |
| 49 | Sing George LDirector | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $2.43M 2,522 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 49 | Zuberbuhler Adolfo FernandoChief Financial Officer |  PAMPampa Energy Inc.Open-market purchase | BUY | $207K 3,136 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 49 | Sing George LDirector | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $1.47M 1,522 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 47 | Shepherd Brian A.Director |  LRNStride, Inc.Open-market purchase | BUY | $375K 4,880 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 47 | Shepherd Brian A.Director | LRNStride, Inc. Open-market purchase | BUY | $545K 7,120 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 47 | Skeete Bernard MChief Accounting Officer |  VLTOVeralto CorpOpen-market sale | SELL | $170K 1,514 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 45 | Manley Michael MarkDirector, CEO and Director |  ANAUTONATION, INC.Open-market purchase | BUY | $682K 3,708 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 45 | Sing George LDirector | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $1.18M 1,224 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 45 | Sing George LDirector | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $1.01M 1,040 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 45 | Manley Michael MarkDirector, CEO and Director | ANAUTONATION, INC. Open-market purchase | BUY | $349K 1,892 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 44 | Treff Douglas JDirector |  CROXCrocs, Inc.Open-market sale | SELL | $1.10M 7,185 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 44 | Clay CraigSenior Advisor |  DFINDonnelley Financial Solutions, Inc.Open-market sale | SELL | $1.89M 28.1K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 44 | Clay CraigSenior Advisor | DFINDonnelley Financial Solutions, Inc. Open-market sale | SELL | $1.45M 21.4K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 44 | Garceau Mary LSVP - CLO and Secretary |  SHWSHERWIN WILLIAMS COOpen-market sale | SELL | $1.36M 3,891 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 44 | Clay CraigSenior Advisor | DFINDonnelley Financial Solutions, Inc. Open-market sale | SELL | $1.45M 21.5K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 43 | Tamer FordDirector, President & CEO |  LSCCLATTICE SEMICONDUCTOR CORPOpen-market purchase | BUY | $295K 2,894 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 43 | Tryniski Mark EDirector |  TBBKBancorp, Inc.Open-market purchase | BUY | — 5,000 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 43 | Tamer FordDirector, President & CEO | LSCCLATTICE SEMICONDUCTOR CORP Open-market purchase | BUY | $585K 5,696 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 42 | Larosa Joseph JEVP General Counsel and Secret | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $509K 527 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 42 | Murphy Robert MadisonDirector |  MUSAMurphy USA Inc.Open-market sale | SELL | $589K 1,000 sh | Nov 4, 2026 traded May 4, 2026 |
| 42 | Szlosek Thomas AEVP & CFO | ANAUTONATION, INC. Open-market purchase | BUY | $100K 551 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 42 | Edmunds C ColemanEVP, Gen Counsel & Corp Sec | ANAUTONATION, INC. Open-market purchase | BUY | $55K 300 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 42 | Sing George LDirector | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $519K 540 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 41 | Turner KamiChief Accounting Officer | DFINDonnelley Financial Solutions, Inc. Open-market sale | SELL | $406K 6,100 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 41 | Turner KamiChief Accounting Officer | DFINDonnelley Financial Solutions, Inc. Open-market sale | SELL | $406K 6,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 41 | Kowaleski John E.Director |  GLOClough Global Opportunities FundOpen-market purchase | BUY | $1,997 365 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 41 | Kowaleski John E.Director |  GLVClough Global Dividend & Income FundOpen-market purchase | BUY | $4,050 700 sh | Nov 4, 2026 traded Nov 3, 2026 |
Kurtz George0B / 238S · 10 late238 trades$60.26M
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98MUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 8 – Sep 166 insiders$2.66M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
BCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K